Evaluation of Bone Density, Serum Total and Ionized Calcium, Alkaline Phosphatase and 25-hydroxy Vitamin D in Papillary Thyroid Carcinoma, and their Relationship with TSH Suppression by Levothyroxine
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 6 (1) , 94
Abstract
Background: This study aimed to evaluate the situation of Bone Mineral Density (BMD), Z score, T score, serum level of corrected and ionized calcium, alkaline phosphatase and 25-hydroxy vitamin D in percutaneous transhepatic cholangiography (PTC) patients and correlation of these variants with thyroid stimulating hormone (TSH) suppression level by levothyroxine. Materials and Methods: Among the patients referred to Esfahan's endocrinology research center, 34 PTC patients (aged 20–50 years) with a history of thyroidectomy and conceived radioactive iodine and suppressive dose of levothyroxine were evaluated in this case–control study, and 38 healthy persons participated as the control group (matched by age and sex, body mass index). Bone density was evaluated with the DEXA method in four areas: Lumbar spine, femoral neck, and trochanter and distal of forearm. A reference laboratory assessed TSH, corrected and ionized calcium, Alkaline phosphatase (ALP) and 25OH vitamin D levels using fasting plasma and evaluated correlation of TSH level with variants by multivariate variance analysis. Results: There was no significant difference in bone density and laboratory data (unless TSH) between the groups. In the PTC group, there was no significant correlation between TSH and difference values of BMD, Z score or T score, corrected calcium (P value = 0.12), ionized calcium (P = 0.54), ALP (P = 0.22) and 25 OH vitamin D (P = 0.38). There was no significant correlation in the TSH subgroups with BMD. The TSH suppression level has no relation with the elevated prevalence of low BMD, hypocalcemia and vitamin D deficiency. Difference in odds ratio was not significant for osteopenia and osteoporosis between the TSH subgroups (TSH < 0.02, >0.02 and 0.1 mu/L). Conclusion: Suppressive therapy with levothyroxine cannot decrease BMD, Z score and T score in PTC patients.Keywords
This publication has 11 references indexed in Scilit:
- Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancerAnnals of Surgical Treatment and Research, 2014
- For whom the bell tolls: Distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseasesBone, 2013
- Effects of Levothyroxine on Bone Mineral Density, Muscle Force, and Bone Turnover Markers: A Cohort StudyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: A prospective controlled studySurgery, 2011
- The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment2008
- Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L‐thyroxine suppressive therapyCurrent Medical Research and Opinion, 2006
- Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinomaEndocrine-Related Cancer, 2005
- The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.2005
- Randomized Trial of Pamidronate in Patients with Thyroid Cancer: Bone Density Is Not Reduced by Suppressive Doses of Thyroxine, But Is Increased by Cyclic Intravenous Pamidronate1The Journal of Clinical Endocrinology & Metabolism, 1998
- A Therapeutic Dilemma: Suppressive Doses of Thyroxine Significantly Reduce Bone Mineral Measurements in Both Premenopausal and Postmenopausal Women with Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 1991